Journal Title：Medicinal Research Reviews

Medicinal Research Reviews publishes timely, critical reviews and opinion-based articles on topics related to medicinal research, broadly defined, to which the authors have made significant contributions.

Appropriate topics include, but are not limited to, the underlying pathophysiology of important diseases and disease vectors; therapeutic approaches to the treatment of various diseases; the properties of molecular targets for therapeutic agents; important new methodologies facilitating the search for therapies; genomics and proteomics; structure-activity correlations of drug series; the development of new imaging and diagnostic tools; drug metabolism; drug delivery; and chemical, pharmacological, pharmacokinetic, pharmacodynamic, and clinical characteristics of important drugs.

Articles are mainly solicited by the Editors; however, voluntary contributions are also encouraged. In the latter case, potential authors are asked to contact the Editor-in-chief with an outline (see below) before beginning to write in order to avoid duplication of effort and to ensure suitability of the topic and the level of coverage.

《醫(yī)學研究評論》及時發(fā)表批判性評論和觀點文章，主題涉及廣義的醫(yī)學研究，作者對此做出了重大貢獻。

適當的主題包括但不限于重要疾病和疾病媒介的潛在病理生理學；治療各種疾病的治療方法；治療劑分子靶點的性質；促進治療研究的重要新方法；基因組學和蛋白質組學；藥物系列的構效相關性；新成像和診斷工具的開發(fā)；藥物代謝；藥物輸送；以及重要藥物的化學、藥理學、藥代動力學、藥效學和臨床特征。

文章主要由編輯征集；但也鼓勵自愿投稿。在后一種情況下，潛在作者需要在開始寫作之前聯系主編并提供一份大綱（見下文），以避免重復勞動并確保主題的適用性和覆蓋范圍。

Medicinal Research Reviews創(chuàng)刊于1981年，由John Wiley and Sons Inc.出版商出版，收稿方向涵蓋醫(yī)學 - 藥學全領域，在行業(yè)領域中學術影響力很大，屬于TOP期刊，國際一流期刊，關注度和專業(yè)度非常高，所以對原創(chuàng)文章要求創(chuàng)新性很高，過審難度很高，如果您有志于TOP期刊，建議關注此刊。平均審稿速度 約稿?周期不定 ，影響因子指數10.9，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。